ALS Center of Excellence

Pranger ALS Clinic

  • Home
  • About
    • What Is ALS?
    • Scott L. Pranger
    • National Advisory Board
    • Faculty & Staff
    • ALS Center of Excellence Brochure
  • Clinic
    • Services
    • Your Visit to the ALS Clinic
    • Patient Portal
    • Durable Medical Equipment
    • Frequently Asked Questions
  • Research
    • Clinical Trials
    • Observational Studies
    • Stem Cell Trial
    • Our Publications
    • Participate in Research at U-M
  • News
  • Patient Care Guide
    • Nutrition
    • Living with ALS
    • Mobility & Independence
    • Patient & Family Support
  • Contact
  • NeuroNetwork
  • Make A Gift

Documentary Staring Down Fate Raises Awareness of Environmental Impact on ALS

May 10, 2018

May 10, 2018

 

Bloomfield Twp., Mich. — Staring Down Fate, a documentary that follows the life of a wolf biologist who develops amyotrophic lateral sclerosis (ALS), made its southeast Michigan debut on Thursday evening (May 10) at the Maple Theater. Jim Hiller, a local philanthropist with an interest in ALS research, sponsored the event.

Jim Hiller, Jeff Mittelstadt, Dr. Eva Feldman

Dr. Eva Feldman, Russell N. DeJong Professor of Neurology and Director of the Program for Neurology Research & Discovery, and Dr. Stephen Goutman, Assistant Professor of Neurology and Director of the ALS Center of Excellence, were featured in the film. The film highlights groundbreaking research from the University of Michigan, finding correlations between environmental issues, like the usage of pesticides in agriculture, and the development of ALS.

Staring Down Fate chronicles the life’s work of North Carolina wolf biologist Chris Lucash. Jeff Mittelstadt, the producer of the film, provided a very true depiction of the struggles that Lucash, as well as his family and community, went through while he fought an unwinnable conflict against his own body. Lucash spent 29 years in the field dedicated to reintroducing the nearly-extinct red wolf into the North Carolina wetlands. It is believed that Lucash’s exposure to pesticides used in the North Carolina farming industry contributed to his onset of ALS.

View the Staring Down Fate trailer below. Watch the full-length film here.

About the ALS Center of Excellence at Michigan Medicine (ACEMM): The ALS Center of Excellence at Michigan Medicine is comprised of an active basic science, translational, and clinical research program and the multidisciplinary ALS clinic. This structure engages collaboration between physicians, basic scientists, nurses, ancillary providers, and research coordinators all working towards better treatments, an understanding of why a person develops ALS, and ultimately a cure for ALS. To learn more about the program, visit https://www.umich-als.org/.

About ALS: Amyotrophic lateral sclerosis (ALS), which is commonly known as Lou Gehrig’s disease, is a progressive fatal neurodegenerative disease that leads to the death of nerve cells in the brain and spinal cord. This in turns causes progressive weakness of voluntary skeletal muscle often leading to death in 2 to 4 years. Current therapies only minimally slow disease and new therapeutic options are critically needed.

Share this:

  • Facebook
  • Twitter
  • LinkedIn

Filed Under: News

ALS Brochure

ALS Brochure


COVID-19 Update

COVID-19 Resources

Join the National ALS Registry. With your help, we can advance research. Learn More.

Resources

Organizations

  • ALS Association
  • ALSA-Michigan Chapter
  • Ann Arbor Active Against ALS
  • ALSA-Northern Ohio Chapter
  • ALS of Michigan
  • National ALS Registry
  • Northeast ALS Consortium
  • Muscular Dystrophy Association

Services

  • Veterans Benefits
  • Social Security Benefits

Newsletter Signup

Subscribe to our mailing list for updates regarding our clinic and research

Useful Links

  • U-M Stem Cell Research
  • Center for Stem Cell Biology
  • Human Embryonic Stem Cell Research
  • Society for Stem Cell Research

RSS Research News

  • Research on aging expands at U-M with $15M in new grants
  • U-M to Conduct Clinical Trial to Test AstraZeneca COVID-19 Vaccine
  • Michigan Medicine and three other medical centers receive $7 million for COVID-19 outpatient convalescent plasma therapy trial

Contact Information

Michigan Medicine
1500 E. Medical Center Drive
Ann Arbor, MI 48109
Phone: 734-936-4000
Contact Michigan Medicine

Connect With Us

Copyright © 2021 Regents of the University of Michigan · Disclaimer · Privacy Statement

  • About UMHS
  • For Patients
  • For Health Professionals
  • For Researchers
  • Home
  • About
    ▼
    • What Is ALS?
    • Scott L. Pranger
    • National Advisory Board
    • Faculty & Staff
    • ALS Center of Excellence Brochure
  • Clinic
    ▼
    • Services
    • Your Visit to the ALS Clinic
    • Patient Portal
    • Durable Medical Equipment
    • Frequently Asked Questions
  • Research
    ▼
    • Clinical Trials
    • Observational Studies
    • Stem Cell Trial
    • Our Publications
    • Participate in Research at U-M
  • News
  • Patient Care Guide
    ▼
    • Nutrition
    • Living with ALS
    • Mobility & Independence
    • Patient & Family Support
  • Contact
  • NeuroNetwork
  • Make A Gift